Search Results - Wolfram Samlowski

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report by Claire V. Ong, Wolfram Samlowski, Wolfram Samlowski, Wolfram Samlowski

    Published in Frontiers in Oncology (2024-03-01)
    Get full text
    Article


  2. 2

    PD-1 monoclonal antibodies as an effective treatment for rare cutaneous malignancies: a case report by Ryan Falk, Wolfram Samlowski, Wolfram Samlowski, Wolfram Samlowski, Amin Hedayat, Amin Hedayat, Amin Hedayat

    Published in Frontiers in Oncology (2025-06-01)
    Get full text
    Article


  3. 3

    Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy by Chalette Lambert-Swainston, Wolfram Samlowski, Wolfram Samlowski, Wolfram Samlowski, Brandon Reynolds, Amin Hedayat, Amin Hedayat

    Published in Frontiers in Oncology (2025-01-01)
    Get full text
    Article


  4. 4

    Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice by Clarice Ho, Wolfram Samlowski

    Published in Current Oncology (2024-06-01)
    Get full text
    Article


  5. 5

    Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series by Raquel Wescott, Wolfram Samlowski

    Published in Current Oncology (2023-10-01)
    Get full text
    Article


  6. 6

    565 Effect of non-overlapping mutations in BRAF, NRAS or NF1 on long-term survival after checkpoint inhibitor-based treatment for metastatic melanoma by Wolfram Samlowski, Alyssa Panning, Gabriel Allred

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  7. 7

    Outcome of Elective Checkpoint Inhibitor Discontinuation in Patients with Metastatic Melanoma Who Achieved a Complete Remission: Real-World Data by Leanne Perez, Wolfram Samlowski, Ruby Lopez-Flores

    Published in Biomedicines (2022-05-01)
    Get full text
    Article


  8. 8

    Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma by Wolfram Samlowski, Nicholas J. Robert, Liwei Chen, Brad Schenkel, Catherine Davis, Andriy Moshyk, Srividya Kotapati, Tayla Poretta, Jeffrey S. Weber

    Published in Cancer Medicine (2023-02-01)
    Get full text
    Article


Search Tools: